Medbox, Inc. Posts 1st Quarter 2012 Financials - Record Revenues Reported
Statements show revenues of over $1.45 million
HOLLYWOOD, Calif., May 7, 2012 /PRNewswire/ -- Medbox, Inc. (Pinksheets: MDBX) (www.medboxinc.com) released first quarter 2012 financial statements for their subsidiary company, Prescription Vending Machines, Inc. (PVM).
The statement shows gross revenues and receivables generated of $1.45 million for the quarter ending March 31. This is the highest quarterly revenue and EBITDA in the company's history.
Prescription Vending Machines, Inc. is engaged in the development, sales and support of prescription medicine dispensing and storage systems. Revenues are derived primarily from machine sales and consulting services.
The company provides their systems, software and consulting services to pharmacies, urgent care centers, clinics, hospitals, and medical groups worldwide. They have been awarded a United States Patent for their primary system — with a number of other patents pending.
The company actively protects their patents and vigorously pursues imitators and others that infringe on the company's proprietary technologies.
For more information on the company, their financials, products or services, please contact the Medbox Investors Relations Department at (800) 762-1452 or go online to www.medboxinc.com.
About Medbox, Inc:
Medbox is a leader in the development, sales and service of automated, biometrically controlled dispensing and storage systems for medicine and merchandise. Medbox has offices throughout the world, including New York, Tokyo and Toronto, and has their corporate headquarters in Los Angeles.
Medbox, Inc. is a publicly traded company, and is listed on the OTC Board, ticker symbol MDBX.
SOURCE Medbox, Inc.
Share this article